Yongqian Shu Selected Research

Yongqian Shu Research Topics

Disease

132	Neoplasms (Cancer) 05/2024 - 04/2009
69	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 04/2009
59	Stomach Neoplasms (Stomach Cancer) 03/2024 - 05/2009
35	Lung Neoplasms (Lung Cancer) 05/2024 - 04/2009
28	Carcinogenesis 10/2023 - 07/2010
26	Neoplasm Metastasis (Metastasis) 01/2024 - 07/2009
17	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 05/2014
12	Disease Progression 01/2023 - 12/2011
11	Adenocarcinoma 03/2024 - 05/2010
11	Adenocarcinoma of Lung 11/2022 - 04/2006
11	Carcinoma (Carcinomatosis) 01/2022 - 11/2008
11	Breast Neoplasms (Breast Cancer) 10/2021 - 07/2009
10	Esophageal Squamous Cell Carcinoma 01/2023 - 01/2017
8	Inflammation (Inflammations) 05/2024 - 06/2014
6	Hypoxia (Hypoxemia) 01/2023 - 12/2013
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022 - 04/2010
5	Melanoma (Melanoma, Malignant) 01/2022 - 02/2014
5	Hypertension (High Blood Pressure) 10/2021 - 01/2019
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 06/2009
4	Lymphatic Metastasis 10/2021 - 05/2014
4	Liposarcoma 02/2015 - 03/2011
3	Anemia 12/2023 - 01/2020
3	Microsatellite Instability 11/2023 - 01/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2023 - 10/2016
3	Pneumonia (Pneumonitis) 01/2023 - 01/2020
3	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2023 - 01/2023
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2021 - 01/2018
3	Colonic Neoplasms (Colon Cancer) 01/2017 - 01/2012
3	Colitis 01/2017 - 06/2014
2	Myocarditis (Carditis) 01/2023 - 01/2020
2	Wounds and Injuries (Trauma) 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

45	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2010
43	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2009
28	Proteins (Proteins, Gene)FDA Link 07/2023 - 04/2009
25	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2006
14	PlatinumIBA 11/2022 - 03/2012
13	CytokinesIBA 10/2023 - 07/2009
12	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 05/2009
12	Tyrosine Kinase InhibitorsIBA 01/2023 - 03/2011
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 07/2009
10	ErbB Receptors (EGF Receptor)IBA 11/2022 - 03/2011
9	Immune Checkpoint InhibitorsIBA 05/2024 - 11/2020
9	Messenger RNA (mRNA)IBA 05/2024 - 04/2009
9	Circular RNAIBA 02/2024 - 01/2018
8	Long Noncoding RNAIBA 01/2021 - 06/2014
8	Gefitinib (Iressa)FDA Link 10/2018 - 03/2011
7	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2016 - 12/2009
6	camrelizumabIBA 03/2024 - 01/2020
6	RNA (Ribonucleic Acid)IBA 01/2024 - 03/2016
6	tislelizumabIBA 01/2023 - 01/2020
6	anlotinibIBA 01/2023 - 01/2020
6	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 12/2010
6	icotinibIBA 08/2017 - 01/2014
5	6-methyladenineIBA 05/2024 - 01/2018
5	HMPL-013IBA 04/2024 - 01/2018
5	Carboplatin (JM8)FDA LinkGeneric 01/2024 - 08/2015
5	sintilimabIBA 12/2023 - 01/2022
5	ChemokinesIBA 10/2023 - 11/2011
5	Docetaxel (Taxotere)FDA Link 12/2022 - 01/2016
5	Bevacizumab (Avastin)FDA Link 11/2022 - 01/2015
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 07/2009
5	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 11/2008
5	Pemetrexed (MTA)FDA Link 01/2021 - 10/2013
4	apatinibIBA 03/2024 - 01/2019
4	LigandsIBA 10/2023 - 01/2018
4	andrographolideIBA 10/2017 - 06/2014
4	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 01/2012
3	Interleukin-17 (Interleukin 17)IBA 01/2024 - 01/2017
3	Gemcitabine FDA Link 03/2023 - 08/2012
3	Indicators and Reagents (Reagents)IBA 01/2023 - 03/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 10/2013
3	Peptides (Polypeptides)IBA 01/2023 - 01/2020
3	toripalimabIBA 01/2023 - 10/2021
3	Irinotecan (Camptosar)FDA LinkGeneric 10/2022 - 01/2011
3	human ERBB2 proteinIBA 11/2021 - 12/2010
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 04/2010
3	Tamoxifen FDA LinkGeneric 01/2021 - 06/2009
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020 - 01/2016
3	SurvivinIBA 06/2014 - 06/2009
3	Small Interfering RNA (siRNA)IBA 05/2014 - 12/2011
3	Vincristine (Oncovin)FDA LinkGeneric 03/2012 - 12/2010
2	MethyltransferasesIBA 05/2024 - 10/2022
2	Sincalide FDA Link 05/2024 - 01/2022
2	N-methyladenosineIBA 05/2024 - 01/2020
2	penpulimabIBA 01/2024 - 01/2023
2	ChromatinIBA 01/2024 - 07/2023
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2023 - 01/2012
2	Interleukin-8 (Interleukin 8)IBA 01/2023 - 04/2022
2	B7-H1 AntigenIBA 01/2023 - 10/2022
2	CrizotinibIBA 01/2023 - 01/2021
2	XELOXIBA 01/2023 - 07/2021
2	rezivertinibIBA 01/2023 - 11/2022
2	osimertinibIBA 11/2022 - 12/2020
2	Histones (Histone)IBA 10/2022 - 01/2021
2	abivertinibIBA 01/2022 - 01/2021

Therapy/Procedure

63	Therapeutics 05/2024 - 08/2009
63	Drug Therapy (Chemotherapy) 04/2024 - 04/2010
17	Immunotherapy 05/2024 - 01/2012
9	Adjuvant Chemotherapy 01/2023 - 03/2012
2	Chemoradiotherapy 01/2024 - 01/2021